Comparative Pharmacology
Head-to-head clinical analysis: PHENAPHEN 650 W CODEINE versus PHENAPHEN W CODEINE NO 2.
Peer-Reviewed Evidence
Head-to-head clinical analysis: PHENAPHEN 650 W CODEINE versus PHENAPHEN W CODEINE NO 2.
PHENAPHEN-650 W/ CODEINE vs PHENAPHEN W/ CODEINE NO. 2
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Acetaminophen: Weak COX-1 and COX-2 inhibitor in CNS, antipyretic via hypothalamic heat-regulating center. Codeine: Prodrug converted to morphine; mu-opioid receptor agonist.
Codeine is an opioid agonist with affinity for mu-opioid receptors, producing analgesia, cough suppression, and sedation. Acetaminophen is a centrally acting analgesic and antipyretic with unclear mechanism, possibly involving COX-2 inhibition and cannabinoid receptor activation.
Acetaminophen 650 mg and codeine 60 mg orally every 4 hours as needed for pain; maximum acetaminophen 3 g/day.
1-2 tablets (codeine 15-30 mg, acetaminophen 325-650 mg) every 4 hours as needed for pain; maximum: 12 tablets per day.
None Documented
None Documented
Acetaminophen: 2-3 hours (normal liver function); prolonged in liver disease (up to 5-10 hours) or overdose. Codeine: 2.5-3.5 hours; active metabolite morphine ~2 hours. Clinical context: half-life affects dosing interval; accumulation in hepatic or renal impairment.
Phenacetin: terminal half-life ~0.5-2 hours (rapidly eliminated; active metabolite APAP has half-life ~2-3 hours). Codeine: terminal half-life ~2.5-4 hours (increased in CYP2D6 poor metabolizers). Acetaminophen: terminal half-life ~1.5-3 hours (prolonged in hepatic impairment or overdose). Clinical context: half-lives are shortened with chronic use due to autoinduction (phenacetin) and unchanged with therapeutic doses.
Acetaminophen: renal excretion of conjugates (glucuronide ~55%, sulfate ~30%, cysteine/mercapturate ~4%), with <5% unchanged. Codeine: renal excretion as codeine (~10%), norcodeine (~10%), morphine (~10%), and their conjugates; total 70-90% in urine as glucuronide conjugates.
Phenacetin (active metabolite): renal elimination of conjugated metabolites, primarily as sulfate and glucuronide conjugates; ~60% renal. Codeine: ~90% renal, with 5-15% as free codeine, 10% as norcodeine, and 40-70% as conjugated morphine and norcodeine; ~10% fecal. Apap (acetaminophen): renal elimination of conjugated metabolites, with ~85% excreted in urine as sulfate and glucuronide conjugates, ~5% as unchanged drug, and <5% as cysteine/mercapturate conjugates.
Category D/X
Category D/X
Opioid Agonist
Opioid Agonist